Multiple Myeloma

  • Thomas Moehler
  • Hartmut Goldschmidt

Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 183)

Table of contents

  1. Front Matter
    Pages i-xxiii
  2. History and Epidemiology

    1. Front Matter
      Pages 1-1
    2. Robert A. Kyle, David P. Steensma
      Pages 3-23
    3. Nikolaus Becker
      Pages 25-35
  3. Pathophysiology

  4. Clinical Features

    1. Front Matter
      Pages 111-111
    2. Jens Hillengass, Thomas Moehler, Michael Hundemer
      Pages 113-131
    3. Stefan Delorme, Andrea Baur-Melnyk
      Pages 133-147
  5. Therapy

    1. Front Matter
      Pages 149-149
    2. Kevin D. Boyd, Faith E. Davies, Gareth J. Morgan
      Pages 151-187
    3. Murielle Roussel, Thierry Facon, Philippe Moreau, Jean-Luc Harousseau, Michel Attal
      Pages 189-206
    4. Thomas Moehler, Hartmut Goldschmidt
      Pages 239-271
    5. Gösta Gahrton
      Pages 273-284
    6. Sonja Krause, Jürgen Debus, Dirk Neuhof
      Pages 285-291
    7. Heinz Ludwig, Niklas Zojer
      Pages 307-333
  6. Back Matter
    Pages 335-339

About this book


Multiple myeloma is currently still an incurable disease, but during the past decade knowledge of its molecular pathogenesis has increased rapidly. This has led to remarkable progress in both diagnosis and therapy. In particular, the approval of novel and first-in-class drugs such as thalidomide, bortezomib, and lenalidomide means that multiple myeloma now stands at the forefront of advances in oncology drug development. This book, written by internationally acknowledged experts, covers a wide range of topics relating to multiple myeloma, including history, epidemiology, pathophysiology, clinical features, staging, and prognostic systems. The principal focus, however, is on therapy, with detailed information on the various promising treatment options which give hope that this cancer will be transformed into a chronic disease or even become curable. Individualized therapy and the variety of supportive treatment options, as described in this volume, will help in achieving this goal, as well as in reducing adverse events and improving quality of life.


ABSCT Kyphoplasty Plasma cell disorders

Editors and affiliations

  • Thomas Moehler
    • 1
  • Hartmut Goldschmidt
    • 2
  1. 1.Medizinische Klinik und Poliklinik, Abt. Hämatologie, Onkologie undUniversitätsklinikum HeidelbergHeidelbergGermany
  2. 2.Medizinische Klinik und Poliklinik, Abt. Innere Medizin VUniversitätsklinikum HeidelbergHeidelbergGermany

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 2011
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Medicine Medicine (R0)
  • Print ISBN 978-3-540-85771-6
  • Online ISBN 978-3-540-85772-3
  • Series Print ISSN 0080-0015
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Oncology & Hematology